莱美药业取得两项药品注册证书

Core Viewpoint - The company has received approval from the National Medical Products Administration for two new drug registrations, indicating a positive development in its product pipeline [1] Group 1: Drug Approvals - The company has obtained a drug registration certificate for Nicorandil tablets (5mg), which are indicated for the treatment of angina pectoris [1] - The company has also received approval for Ketorolac Tromethamine injection (1ml: 30mg), which is suitable for short-term treatment of moderate to severe postoperative pain [1]